 | • レポートコード：MRC2202A018 • 出版社/出版日：Persistence Market Research / 2021年12月10日 • レポート形態：英文、PDF、219ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界のウェアラブルインジェクター市場について調査・分析し、エグゼクティブサマリー、市場概要、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、価格分析、製品別（身体装着型パッチインジェクター、オフボディ装着型インジェクター）分析、流通チャネル別（病院薬局、小売薬局、Eコマース）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成でまとめております。 ・エグゼクティブサマリー ・市場概要 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・価格分析 ・世界のウェアラブルインジェクター市場規模：製品別（身体装着型パッチインジェクター、オフボディ装着型インジェクター） ・世界のウェアラブルインジェクター市場規模：流通チャネル別（病院薬局、小売薬局、Eコマース） ・世界のウェアラブルインジェクター市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Wearable Injectors Market- Scope of Report
The latest publication by Persistence Market Research on the wearable injectors market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for wearable injectors market and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the wearable injectors market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the wearable injectors market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the wearable injectors market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the wearable injectors market offers information divided into three important segments – product, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Body-worn Patch Injectors
Off-body Worn Injectors
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
e-Commerce
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for wearable injectors over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the wearable injectors market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the wearable injectors market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the wearable injectors market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope
2.3. Key Inclusion & Exclusion
3. Key Success Factors
3.1. Product Adoption Analysis
3.2. List of Manufacturers and Distributors
3.3. Key Regulations by Manufacturers
3.4. Reimbursement and Key Regulatory Scenario
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Outlook
4.1.2. Global Gross Domestic Product by Region & Country
4.1.3. Global Healthcare Expenditure Outlook
4.2 Forecast Factors – Relevance & Impact
4.2.1. Increasing prevalence of Cancer
4.2.2. Increasing prevalence of diabetes
4.2.3. Advancement in technology
4.2.4. Increasing awareness regarding lifestyle management
4.2.5. Cost of the Product
4.2.6. Product Features
4.2.7. Technological Advancements
4.3 Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. COVID-19 Crisis Impact Analysis
5.1. Current COVID19 and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 financial analysis
5.4. COVID19 and Impact Analysis
5.4.1. Revenue by Product
5.4.2. Revenue by Country
5.5. 2020 Market Scenario
6. Global Wearable Injectors Market Volume (in Volume ‘000 Units) Analysis 2016-2020 and Forecast, 2021-2031
6.1. Historical Market Volume (Units) Analysis, 2016-2020
6.2. Current and Future Market Volume (Units) Projections, 2021-2031
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Wearable Injectors Market – Pricing Analysis
7.1. Country Pricing Analysis by Product
7.2. Global Average Pricing Analysis Benchmark
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Average Pricing Analysis Benchmark
8. Global Wearable Injectors Market Value Analysis 2016-2020 and Forecast, 2021-2031
8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Wearable Injectors Market Value (Size US$ Mn) Analysis 2016-2020 and Forecast 2021-2031,By Product
9.1. Introduction/Key Findings
9.2. Historical Market Value (US$ Mn) and Volume (Units) Analysis, By Product, 2016-2020
9.3. Current and Future Market Value (US$ Mn) and Volume (Units) Projections, By Product, 2021-2031
9.3.1. Body-worn patch injector
9.3.2. Off-body worn injectors
9.4. Market Attractiveness By Product
10. Global Wearable Injectors Market Value (Size US$ Mn) Analysis 2016-2020 and Forecast 2021-2031,By Distribution Channel
10.1. Introduction/Key Findings
10.2. Historical Market Value (US$ Mn) Analysis, By Distribution Channel, 2016-2020
10.3. Current and Future Market Value (US$ Mn) Projections, By Distribution Channel, 2021-2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. E-commerce
10.4. Market Attractiveness By Distribution Channel
11. Global Wearable Injectors Market Value (Size US$ Mn) Analysis 2016-2020 and Forecast 2021-2031,By Region
11.1. Introduction/Key Findings
11.2. Historical Market Value (US$ Mn) Analysis, By Region, 2016-2020
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East & Africa
11.4 Market Attractiveness By Region
12. North America Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
12.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Distribution Channel
12.4. Market Attractiveness Analysis
13. Latin America Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
13.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Distribution Channel
13.4. Market Attractiveness Analysis
14. Europe Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
14.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. U.K.
14.3.1.2. Germany
14.3.1.3. France
14.3.1.4. Italy
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Rest of Europe
14.3.2. By Product
14.3.3. By Distribution Channel
14.4. Market Attractiveness Analysis
15. South Asia Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
15.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Distribution Channel
15.4. Market Attractiveness Analysis
16. East Asia Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
16.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Distribution Channel
16.4. Market Attractiveness Analysis
17. Oceania Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
17.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Distribution Channel
17.4. Market Attractiveness Analysis
18. Middle East & Africa Wearable Injectors Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016-2020
18.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.2. Turkey
18.3.2.1. South Africa
18.3.2.2. GCC Countries
18.3.2.3. Rest of Middle East & Africa
18.3.3. By Product
18.3.4. By Distribution Channel
18.4 Market Attractiveness Analysis
19. Countries Wearable Injectors Market Analysis 2016-2020, and Forecast 2021-2031
19.1. U.S. Wearable Injectors Market Analysis
19.1.1. By Product
19.1.2. By Distribution Channel
19.1.3. Pricing Analysis
19.2. Canada Wearable Injectors Market Analysis
19.2.1. By Product
19.2.2. By Distribution Channel
19.3. Brazil Wearable Injectors Market Analysis
19.3.1. By Product
19.3.2. By Distribution Channel
19.4. Mexico Wearable Injectors Market Analysis
19.4.1. By Product
19.4.2. By Distribution Channel
19.5. Argentina Wearable Injectors Market Analysis
19.5.1. By Product
19.5.2. By Distribution Channel
19.6. U.K. Wearable Injectors Market Analysis
19.6.1. By Product
19.6.2. By Distribution Channel
19.7. Germany Wearable Injectors Market Analysis
19.7.1. By Product
19.7.2. By Distribution Channel
19.8. France Wearable Injectors Market Analysis
19.8.1. By Product
19.8.2. By Distribution Channel
19.9. Italy Wearable Injectors Market Analysis
19.9.1. By Product
19.9.2. By Distribution Channel
19.10. Spain Wearable Injectors Market Analysis
19.10.1. By Product
19.10.2. By Distribution Channel
19.11. Russia Wearable Injectors Market Analysis
19.11.1. By Product
19.11.2. By Distribution Channel
19.12. BENELUX Wearable Injectors Market Analysis
19.12.1. By Product
19.12.2. By Distribution Channel
19.13. India Wearable Injectors Market Analysis
19.13.1. By Product
19.13.2. By Distribution Channel
19.14. ASEAN Wearable Injectors Market Analysis
19.14.1. By Product
19.14.2. By Distribution Channel
19.15. China Wearable Injectors Market Analysis
19.15.1. By Product
19.15.2. By Distribution Channel
19.16. Japan Wearable Injectors Market Analysis
19.16.1. By Product
19.16.2. By Distribution Channel
19.17. South Korea Wearable Injectors Market Analysis
19.17.1. By Product
19.17.2. By Distribution Channel
19.18. Australia Wearable Injectors Market Analysis
19.18.1. By Product
19.18.2. By Distribution Channel
19.19. New Zealand Wearable Injectors Market Analysis
19.19.1. By Product
19.19.2. By Distribution Channel
19.20. GCC Countries Wearable Injectors Market Analysis
19.20.1. By Product
19.20.2. By Distribution Channel
19.21. Turkey Wearable Injectors Market Analysis
19.21.1. By Product
19.21.2. By Distribution Channel
19.22. South Africa Wearable Injectors Market Analysis
19.22.1. By Product
19.22.2. By Distribution Channels
20. Market Structure Analysis
20.1. Market Analysis By Tier of Companies
20.2. Market Share Analysis By Key Players
20.3. Market Presence Analysis
20.3.1. By Regional footprint of Players
20.3.2. Service foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Medtronic Plc.
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.1.5.1. Marketing Strategy
21.2.1.5.2. Product Strategy
21.2.1.5.3. Channel Strategy
21.2.2. Enable Injections LLC
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.2.5.1. Marketing Strategy
21.2.2.5.2. Product Strategy
21.2.2.5.3. Channel Strategy
21.2.3. Becton, Dickinson and Company
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.3.5.1. Marketing Strategy
21.2.3.5.2. Product Strategy
21.2.3.5.3. Channel Strategy
21.2.4. Insulet Corporation
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.4.5.1. Marketing Strategy
21.2.4.5.2. Product Strategy
21.2.4.5.3. Channel Strategy
21.2.5. Dexcom, Inc.
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.5.5.1. Marketing Strategy
21.2.5.5.2. Product Strategy
21.2.5.5.3. Channel Strategy
21.2.6. Valeritas,Inc
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.6.5.1. Marketing Strategy
21.2.6.5.2. Product Strategy
21.2.6.5.3. Channel Strategy
21.2.7. Ypsomed Group
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.7.5.1. Marketing Strategy
21.2.7.5.2. Product Strategy
21.2.7.5.3. Channel Strategy
21.2.8. West Pharmaceutical Services, Inc.
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
21.2.8.4. Sales Footprint
21.2.8.5. Strategy Overview
21.2.8.5.1. Marketing Strategy
21.2.8.5.2. Product Strategy
21.2.8.5.3. Channel Strategy
21.2.9. Bespak
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
21.2.9.4. Sales Footprint
21.2.9.5. Strategy Overview
21.2.9.5.1. Marketing Strategy
21.2.9.5.2. Product Strategy
21.2.9.5.3. Channel Strategy
21.2.10. Amgen Inc.
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
21.2.10.4. Sales Footprint
21.2.10.5. Strategy Overview
21.2.10.5.1. Marketing Strategy
21.2.10.5.2. Product Strategy
21.2.10.5.3. Channel Strategy
22. Assumptions & Acronyms
23. Research Methodology
Table 01: Global Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By ProductTable 02: Global Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 03: Global Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 04: Global Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 05: North America Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 06: North America Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 07: North America Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 08: North America Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 09: Latin America Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 10: Latin America Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 11: Latin America Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 12: Latin America Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 13 Europe Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14: Europe Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 15: Europe Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 16: Europe Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 17: South Asia Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 18: South Asia Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 19: South Asia Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 20: South Asia Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 21: East Asia Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 22: East Asia Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 23: East Asia Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 24: East Asia Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 25: Oceania Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 26: Oceania Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 27: Oceania Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 28: Oceania Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 29: MEA Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 30: MEA Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 31: MEA Wearable Injectors Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product
Table 32: MEA Wearable Injectors Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel